# Omega-3 Supplementation for LIver VolumE Reduction Study (OLIVER) Study

> **NCT03972319** · EARLY_PHASE1 · UNKNOWN · sponsor: **Khoo Teck Puat Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Fatty Liver
- Bariatric Surgery Candidate

## Interventions

- **DIETARY_SUPPLEMENT:** 2 capsules of Concentrated omega-3 triglycerides- fish 1000mg (600mg Eicosapentaenoic acid (EPA), 1400mg Docosahexaenoic acid (DHA)) per day

## Key facts

- **NCT ID:** NCT03972319
- **Lead sponsor:** Khoo Teck Puat Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-17
- **Primary completion:** 2022-12
- **Final completion:** 2023-04
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03972319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03972319, "Omega-3 Supplementation for LIver VolumE Reduction Study (OLIVER) Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03972319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*